Clinical Trial Update: Nimotuzumab Combined With Chemoradiotherapy for Unresectable Locally Advanced Squamous Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating nimotuzumab with chemoradiotherapy in unresectable locally advanced non-small cell lung cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Nimotuzumab (nimotuzumab)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Non-small-cell Lung Cancer | Phase 2 | Status: COMPLETED